TLR4 and neoplasm: When LPS, a component of gram-negative bacteria, enters the bloodstream, it can activate an inflammatory cascade by binding to TLR4 on immune cells, stimulating the release of proinflammatory cytokines and chemokines [79], which may act systemically upon the tumour microenvironment.